Operating Lease, Right-of-Use Asset in USD of Ovid Therapeutics Inc. from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ovid Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2021 to Q3 2025.
  • Ovid Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $11.9M, a 8.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Ovid Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $11.9M -$1.16M -8.9% Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $12.2M -$1.14M -8.55% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $12.5M -$1.12M -8.21% Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $12.8M -$1.1M -7.9% Dec 31, 2024 10-Q 2025-11-12
Q3 2024 $13.1M -$1.08M -7.6% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $13.4M -$1.06M -7.32% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $13.6M -$1.04M -7.1% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $13.9M -$1.03M -6.89% Dec 31, 2023 10-K 2025-03-11
Q3 2023 $14.2M -$1.02M -6.74% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $14.4M -$1.03M -6.64% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $14.7M -$1.02M -6.51% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $14.9M +$14.9M Dec 31, 2022 10-K 2024-03-08
Q3 2022 $15.2M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $15.4M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $15.7M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.